GEXVal Invited to Speak at Certainty Japan 2026
2026/6/18
GEXVal Inc.June 18, 2026 GEXVal Head of R&D CMC Selected as Invited Speaker at Certainty Japan 2026 GEXV […]
GEXVal CEO Selected as Invited Speaker at CPHI Japan 2026
2026/4/15
GEXVal Inc.April 15, 2026 GEXVal CEO Selected as Invited Speaker at Drug Discovery Symposium of CPHI Japan 202 […]
Announcement of Appointment of External Director
2026/3/25
GEXVal Inc.March 25, 2026 Unlocking the Value of Drug Discovery Through IP Strategy — Appointment of of Dr. Ka […]
GEXVal CTO to Present at the Annual Meeting of the PSJ
2026/3/25
GEXVal Inc.March 25, 2026 GEXVal CTO to Present at the 146th Annual Meeting of the Pharmaceutical Society of J […]
GEXVal Receives Formal PMDA Opinion Letter for Lead Program GXV-001
2026/3/24
GEXVal Inc.March 24, 2026 GEXVal Receives Formal PMDA Opinion Letter for Lead Program GXV-001-Post-Operative D […]